Zimmer Biomet Maps Robotic Orthopedic Surgery Framework

Surgeon-Guided Autonomy links planning, surgery and recovery, but remains an aspirational category rather than a shipping product.

Updated on Nov. 6, 2026 in Robotics

Zimmer Biomet Maps Robotic Orthopedic Surgery Framework

Zimmer Biomet introduced Surgeon-Guided Autonomy, a new technology category for orthopedic surgery, at a company-sponsored symposium at the AAHKS Annual Meeting. It is a technology category and aspirational framework rather than a product, and the company also launched an awareness campaign called Surgeon-Guided AutonoMe.

Why it matters

The framework ties surgical planning, surgery and recovery into one continuous loop, reflecting a broader push in orthopedics to connect intelligence, robotics and data across the care journey. Because it is announced as a category rather than a shipping system, its trajectory will depend on the products the company eventually builds under it.

The announcement provides no benchmark, accuracy figure or performance metric for the framework, which is defined as a three-stage model of Predict, Perform and Recover. Its technical claims are therefore architectural and unquantified at this stage.

The players

Zimmer Biomet

A publicly traded orthopedic device maker (NYSE and SIX: ZBH) whose surgical portfolio spans robotics, implants and data-driven planning tools.

Jonathan Vigdorchik

Chief Science, Technology and Medical Affairs Officer at Zimmer Biomet, overseeing the company's technology and clinical science strategy.

Dr. Nicolas Piuzzi

An orthopedic surgeon affiliated with Cleveland Clinic who is involved in the surgeon-led discussion of the framework.

The details

Surgeon-Guided Autonomy is built around three stages: Predict, Perform and Recover. The framework is meant to translate surgeon-defined intent into action across planning, surgical execution and post-operative recovery, with intelligent systems linking those stages. Zimmer Biomet presents it as a category for organizing future robotics and data tools rather than a single device.

Timeline

  1. November 6, 2026: Zimmer Biomet announces Surgeon-Guided Autonomy and the AutonoMe campaign.

  2. Through the weekend: Booth #608 is open at the conference for exploring the products.

The Tech Race

Surgeon-Guided Autonomy positions Zimmer Biomet to compete in the surgical-robotics race with a category framework rather than a single shipping system. Its success will be judged against rival robotic platforms once specific products are released under the category.

The framework is not yet a product, so patients and surgeons cannot use it today. Availability, pricing and timing have not been announced, and surgeons interested in the technology can view the products at Booth #608 during the conference weekend.

The takeaway

Watch for the first named products that Zimmer Biomet ties to the Predict, Perform and Recover stages, since those will show whether the framework becomes a real system. Surgeons evaluating orthopedic robotics should track those product launches and any clinical data released alongside them.

Further reading

For broader context on where surgical machines are heading, explore our Robotics coverage.